Mercer Global Advisors »

Calidi Biotherapeutics shares owned by Mercer Global Advisors

Quarter-by-quarter ownership of Calidi Biotherapeutics (CLDI) shares owned by Mercer Global Advisors from 13F filings

Historical chart of Mercer Global Advisors investment in Calidi Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Calidi Biotherapeutics held by Mercer Global Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Calidi Biotherapeutics by Mercer Global Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $9 50 0.18

More positions owned by Mercer Global Advisors

Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Dimensional Etf Trust Us Cor Equ 2 Etf (DFAC)
Ishares Tr Msci Usa Mmentm (MTUM)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Dimensional Etf Trust Us High Prof Etf (DUHP)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Dimensional Etf Trust Intl Core Equity (DFIC)
Ishares Tr Msci Intl Moment (IMTM)
Dimensional Etf Trust Internatnal Val (DFIV)
Dimensional Etf Trust Intl High Profit (DIHP)
American Centy Etf Tr Avan Us Smal Etf (AVSC)
Ishares Tr National Mun Etf (MUB)

View all positions for Mercer Global Advisors

Top funds holding Calidi Biotherapeutics

Geode Capital Management
HighTower Advisors
Jane Street
Independent Advisor Alliance
Rs Crum
SRS Capital Advisors
Private Advisor
Vanguard Capital Management
Belpointe Asset Management
Northern Trust
RFG Advisory
Farther Finance Advisors
Morgan Stanley
UBS Group
Advisor Group Holdings

View all funds holding Calidi Biotherapeutics